HBC Hofseth Biocare

Hofseth Biocare ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Hofseth Biocare ASA: KEY INFORMATION RELATING TO THE SUBSEQUENT OFFERING

Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a contemplated subsequent offering (the "Subsequent Offering").

Date on which the terms of the Subsequent Offering was announced:16 October 2020
Last day including right:15 October 2020
First day excluding right:16 October 2020
Record date:19 October 2020
EGM date:On or about 11 November 2020
Maximum number of new shares:4,938,271
Subscription price:NOK 8.10
Shall the rights be listedNo

This information is published in accordance with the requirements of the Continuing Obligations.

EN
15/10/2020

Underlying

HBCHofseth Biocare

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hofseth Biocare

 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subs...

Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placem...

9h / 40m 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Terms of the Subsequent Offering

Hofseth BioCare ASA: Terms of the Subsequent Offering NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company, ...

November 7, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT

Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT HBC recorded total operating revenues of NOK 54.9 million in the third quarter of 2025, compared to NOK 67.9 million in the same period last year. Net operating revenues were NOK 54.8 million, reflecting lower commodity prices and a weaker U.S. dollar during the quarter. EBITDA for the quarter was NOK -21.1 million (-21.0) and the operational EBITDA* amounted to NOK -12.9 million (-13.9m), excluding non-recurring and strategic development costs such as clinical studies, R&D expenses, and Berkåk project costs. Cash and cash equival...

November 7, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding (i) the completion of a private placement (the "Private Placement") of new shares in the Company the "Offer Shares"), the completion of which by delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") is subject to, among other things, an extraordinary general meeting (the "EGM") resolving to issue the T2 Offer Shares in the Private Placement and (ii) a potential subsequent repair offering which i...

October 30, 2025 1 EN
 PRESS RELEASE
Free
HBC HOFSETH BIOCARE

Hofseth BioCare ASA: Mandatory Notification of Trade

Hofseth BioCare ASA: Mandatory Notification of Trade Reference is made to the stock exchange announcement by Hofseth Biocare ASA ("HBC" or the "Company") on 27 October 2025 regarding completion of a private placement (the "Private Placement") of new shares in the Company. In the Private Placement, Hofseth International AS was allocated 28,666,666 new shares at the subscription price of NOK 1.80. Please refer to the attached notification form for further information. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19. For furth...

October 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch